Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Insulin resistance correlated with the severity of liver histology in Japanese NAFLD patients: a multicenter retrospective study.

Kessoku T, Yoneda M, Sumida Y, Eguchi Y, Fujii H, Hyogo H, Ono M, Kawaguchi T, Nakajima A; Japan Study Group of NAFLD.

J Clin Gastroenterol. 2015 Feb;49(2):169-70. doi: 10.1097/MCG.0000000000000186. No abstract available.

PMID:
25014241
2.

Evaluation of metabolic syndrome and nonalcoholic steatohepatitis.

Sertoglu E, Uyanik M, Kayadibi H.

J Clin Gastroenterol. 2015 Apr;49(4):352-3. doi: 10.1097/MCG.0000000000000280. No abstract available.

PMID:
25551207
3.

Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.

Jung KY, Cho SY, Kim HJ, Kim SB, Song IH.

J Clin Gastroenterol. 2014 Nov-Dec;48(10):883-8. doi: 10.1097/MCG.0000000000000065.

PMID:
24440936
4.

Non-alcoholic fatty liver disease: A sign of systemic disease.

Reccia I, Kumar J, Akladios C, Virdis F, Pai M, Habib N, Spalding D.

Metabolism. 2017 Jul;72:94-108. doi: 10.1016/j.metabol.2017.04.011. Epub 2017 Apr 27. Review.

PMID:
28641788
5.

Non-alcoholic fatty liver disease (NAFLD) in different populations: A clinical and epidemiological study - sample of São José do Rio Preto.

Andrade GC, Fujise LH, Santana JE Filho, Oliveira F, Silva Rde C.

Rev Assoc Med Bras (1992). 2016 May-Jun;62(3):218-26. doi: 10.1590/1806-9282.62.03.218.

6.

Nonalcoholic fatty liver disease in Asia: emerging perspectives.

Seto WK, Yuen MF.

J Gastroenterol. 2017 Feb;52(2):164-174. doi: 10.1007/s00535-016-1264-3. Epub 2016 Sep 16. Review.

PMID:
27637587
7.

Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.

Ercin CN, Dogru T, Genc H, Celebi G, Aslan F, Gurel H, Kara M, Sertoglu E, Tapan S, Bagci S, Rizzo M, Sonmez A.

Metab Syndr Relat Disord. 2015 Sep;13(7):319-25. doi: 10.1089/met.2015.0018. Epub 2015 May 26.

PMID:
26011302
8.

[Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].

Andreozzi P, Viscogliosi G, Colella F, Subic M, Cipriani E, Marigliano B, Verrusio W, Servello A, Ettorre E, Marigliano V.

Recenti Prog Med. 2012 Dec;103(12):570-4. doi: 10.1701/1206.13358. Italian.

PMID:
23258240
9.

The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.

Campanati A, Ganzetti G, Di Sario A, Damiani A, Sandroni L, Rosa L, Benedetti A, Offidani A.

J Gastroenterol. 2013 Jul;48(7):839-46. doi: 10.1007/s00535-012-0678-9. Epub 2012 Oct 13.

PMID:
23065020
10.

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Buzzetti E, Pinzani M, Tsochatzis EA.

Metabolism. 2016 Aug;65(8):1038-48. doi: 10.1016/j.metabol.2015.12.012. Epub 2016 Jan 4. Review.

PMID:
26823198
11.

FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism.

Gökmen FY, Ahbab S, Ataoğlu HE, Türker BÇ, Çetin F, Türker F, Mamaç RY, Yenigün M.

Clinics (Sao Paulo). 2016 Apr;71(4):221-5. doi: 10.6061/clinics/2016(04)08.

12.
13.

Cryptogenic cirrhosis: metabolic liver disease due to insulin resistance.

De BK, Mani S, Mandal SK, Mondal SS, Bhattacharya R, Pramanik AB, Sau D, Bhattacharjee K, Joardar S.

Indian J Med Sci. 2010 Nov;64(11):508-19. doi: 10.4103/0019-5359.102124.

PMID:
23051943
14.

Chronic fructose intake accelerates non-alcoholic fatty liver disease in the presence of essential hypertension.

Lírio LM, Forechi L, Zanardo TC, Batista HM, Meira EF, Nogueira BV, Mill JG, Baldo MP.

J Diabetes Complications. 2016 Jan-Feb;30(1):85-92. doi: 10.1016/j.jdiacomp.2015.10.008. Epub 2015 Oct 19.

PMID:
26597602
15.

Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.

Dongiovanni P, Meroni M, Baselli GA, Bassani GA, Rametta R, Pietrelli A, Maggioni M, Facciotti F, Trunzo V, Badiali S, Fargion S, Gatti S, Valenti L.

Clin Sci (Lond). 2017 Jun 7;131(12):1301-1315. doi: 10.1042/CS20170175. Print 2017 Jun 1.

PMID:
28468951
16.

Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.

Nakahara T, Hyogo H, Yoneda M, Sumida Y, Eguchi Y, Fujii H, Ono M, Kawaguchi T, Imajo K, Aikata H, Tanaka S, Kanemasa K, Fujimoto K, Anzai K, Saibara T, Sata M, Nakajima A, Itoh Y, Chayama K, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease.

J Gastroenterol. 2014 Nov;49(11):1477-84. doi: 10.1007/s00535-013-0911-1. Epub 2013 Nov 26.

PMID:
24277052
17.

Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children?

Atabek ME, Selver Eklioglu B, Akyürek N.

Eat Weight Disord. 2014 Dec;19(4):495-501. doi: 10.1007/s40519-014-0129-0. Epub 2014 May 21.

PMID:
24844310
18.

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.

Yki-Järvinen H.

Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10. doi: 10.1016/S2213-8587(14)70032-4. Epub 2014 Apr 7. Review.

PMID:
24731669
19.

[Non-alcoholic fatty liver disease. How and who to screen].

Terán Lantarón A, Crespo García J.

Gastroenterol Hepatol. 2011 Apr;34(4):278-88. doi: 10.1016/j.gastrohep.2010.11.010. Epub 2011 Mar 22. Review. Spanish.

PMID:
21429628
20.

Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.

Bruno Ade S, Rodrigues MH, Alvares MC, Nahas-Neto J, Nahas EA.

Climacteric. 2014 Aug;17(4):465-71. doi: 10.3109/13697137.2014.881353. Epub 2014 Feb 11.

PMID:
24517420

Supplemental Content

Support Center